Michael Shapiro to Hypercholesterolemia
This is a "connection" page, showing publications Michael Shapiro has written about Hypercholesterolemia.
Connection Strength
4.776
-
Shapiro MD, Taub PR, Louie MJ, Lei L, Ballantyne CM. Efficacy and safety of bempedoic acid in patients with and without metabolic syndrome: Pooled analysis of data from four phase 3 clinical trials. Atherosclerosis. 2023 Aug; 378:117182.
Score: 0.841
-
Mahmood T, Shapiro MD. Future role of proprotein convertase subtilisin/kexin type 9 inhibitors in preventive cardiology. Curr Opin Cardiol. 2019 09; 34(5):519-525.
Score: 0.645
-
Shapiro MD, Minnier J, Tavori H, Kassahun H, Flower A, Somaratne R, Fazio S. Relationship Between Low-Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab. J Am Heart Assoc. 2019 02 19; 8(4):e010932.
Score: 0.622
-
Kaufman TM, Warden BA, Minnier J, Miles JR, Duell PB, Purnell JQ, Wojcik C, Fazio S, Shapiro MD. Application of PCSK9 Inhibitors in Practice. Circ Res. 2019 01 04; 124(1):32-37.
Score: 0.616
-
Kaufman TM, Duell PB, Purnell JQ, Wójcik C, Fazio S, Shapiro MD. Application of PCSK9 Inhibitors in Practice: Challenges and Opportunities. Circ Res. 2017 08 18; 121(5):499-501.
Score: 0.560
-
Shapiro MD, Fazio S, Tavori H. Targeting PCSK9 for therapeutic gains. Curr Atheroscler Rep. 2015 Apr; 17(4):499.
Score: 0.475
-
Miles J, Scotti A, Castagna F, Kuno T, Leone PP, Coisne A, Ludwig S, Lavie CJ, Joshi PH, Latib A, Garcia MJ, Rodriguez CJ, Shapiro MD, Virani SS, Slipczuk L. Long-Term Mortality in Patients With Severe Hypercholesterolemia Phenotype From a Racial and Ethnically Diverse US Cohort. Circulation. 2024 Feb 06; 149(6):417-426.
Score: 0.216
-
Ashburn NP, Snavely AC, Rikhi R, Shapiro MD, Chado MA, Stopyra JP, Mahler SA. Preventive Cardiovascular Care for Hypercholesterolemia in US Emergency Departments: A National Missed Opportunity. Crit Pathw Cardiol. 2023 Dec 01; 22(4):110-113.
Score: 0.215
-
Ashburn NP, Snavely AC, Stanek LS, Shapiro MD, Rikhi RR, Chado MA, Stopyra JP, Mahler SA. Emergency Department Observation Unit Patients Want Evaluation and Treatment for Hypercholesterolemia: A Health Belief Model Study. Crit Pathw Cardiol. 2023 Sep 01; 22(3):91-94.
Score: 0.211
-
Ashburn NP, Snavely AC, Rikhi R, Shapiro MD, Chado MA, Ambrosini AP, Biglari AA, Kitchen ST, Millard MJ, Stopyra JP, Mahler SA. Rarely tested or treated but highly prevalent: Hypercholesterolemia in ED observation unit patients with chest pain. Am J Emerg Med. 2023 Sep; 71:47-53.
Score: 0.209
-
German CA, Shapiro MD. Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9. BioDrugs. 2020 Feb; 34(1):1-9.
Score: 0.166